ArticleMolecular and cellular pediatrics2021

Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.

Lina Driouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.